norethindrone and Drug Withdrawal Symptoms

norethindrone has been researched along with Drug Withdrawal Symptoms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flowers, CE; Hyde, BM; Wilborn, WH1
Hardt, W; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schmidt-Gollwitzer, M1
Diethelm, P; Gray, RH; Parker, RA1
Christiansen, C; Jensen, J; Riis, BJ; Strøm, V1
Policar, M1
Berman, E1

Trials

2 trial(s) available for norethindrone and Drug Withdrawal Symptoms

ArticleYear
Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-act
    British journal of obstetrics and gynaecology, 1981, Volume: 88, Issue:3

    Topics: Amenorrhea; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norethindrone; Pregnancy; Substance Withdrawal Syndrome; Uterine Hemorrhage

1981
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Maturitas, 1989, Volume: 11, Issue:2

    Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation; Substance Withdrawal Syndrome; Time Factors

1989

Other Studies

4 other study(ies) available for norethindrone and Drug Withdrawal Symptoms

ArticleYear
Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
    Obstetrics and gynecology, 1983, Volume: 61, Issue:2

    Topics: Adult; Drug Therapy, Combination; Endometrium; Estrogens, Conjugated (USP); Female; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Microscopy, Electron; Middle Aged; Norethindrone; Norethindrone Acetate; Substance Withdrawal Syndrome; Uterine Hemorrhage

1983
[Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Geburtshilfe und Frauenheilkunde, 1982, Volume: 42, Issue:12

    Topics: Adult; Buserelin; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Evaluation; Endometrium; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Menstruation; Norethindrone; Norethindrone Acetate; Ovulation; Patient Acceptance of Health Care; Substance Withdrawal Syndrome; Uterine Hemorrhage

1982
Clinical experience with multiphasic oral contraceptives.
    The Journal of reproductive medicine, 1986, Volume: 31, Issue:9 Suppl

    Topics: Adult; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Middle Aged; Norethindrone; Progesterone Congeners; Substance Withdrawal Syndrome; Uterine Hemorrhage; Virilism

1986
The once-a-month pill.
    The Journal of reproductive medicine, 1970, Volume: 5, Issue:5

    Topics: Abdomen, Acute; Biopsy; Breast; Chile; Contraceptives, Oral; Dosage Forms; Drug Combinations; Endometrium; Estranes; Female; Headache; Humans; Menstruation; Menstruation Disturbances; Mexico; Mucus; Nausea; Norethindrone; Pain; Peru; Pregnancy; Socioeconomic Factors; Substance Withdrawal Syndrome; Vomiting

1970